Investor · 1 deal
Every published round Pacific Chan took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Navi Medical Technologies | Unnamed stage | 4 Aug 2026 | $6.8m | Participant | Startup Daily (4 Aug 2026), bushletter.com, SmartCompany, raising.fi, PR Newswire, meditechtoday.com, navitechnologies.com, Startup Daily (28 Jul 2026) |
Companies Pacific Chan has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Navi Medical Technologies | Developer of Neonav, a vascular device to help clinicians insert catheters into veins of … | 4 Aug 2026 | 1 | 0 |
Fund closes reported for Pacific Chan, as distinct from the investments it has made.
Companies Pacific Chan has backed that another company then bought. An exit for the holding, not a deal Pacific Chan did.
Stories naming Pacific Chan. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of eight Australian and New Zealand startups whose late-July funding totals $102 million across space capsules, medical devices, livestock breath analysis, sports analytics and AI crop forecasting.
Melbourne paediatric device maker Navi Medical Technologies has banked $6.8 million, led by KP Rx, to take its Neonav catheter tool into the US market following regulatory clearance.
Also navitechnologies.com·meditechtoday.com·PR Newswire·SmartCompany·raising.fi·Startup Daily·bushletter.com